These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 8526118

  • 1. Cell-cell interactions regulate dendritic cell-dependent HIV-1 production in CD4+ T lymphocytes.
    Pinchuk LM, Polacino PS, Agy MB, Klaus SJ, Clark EA.
    Adv Exp Med Biol; 1995; 378():461-3. PubMed ID: 8526118
    [Abstract] [Full Text] [Related]

  • 2. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection.
    Pinchuk LM, Polacino PS, Agy MB, Klaus SJ, Clark EA.
    Immunity; 1994 Jul; 1(4):317-25. PubMed ID: 7534204
    [Abstract] [Full Text] [Related]

  • 3. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW, Vermeiren J, Rafiq K, Lorr K, de Boer M, Ceuppens JL.
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of CD40 ligand in costimulation and T-cell activation.
    Grewal IS, Flavell RA.
    Immunol Rev; 1996 Oct; 153():85-106. PubMed ID: 9010720
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD, Starling GC, Williams LA, Hock BD, Hart DN.
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [Abstract] [Full Text] [Related]

  • 12. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway.
    McLellan AD, Sorg RV, Williams LA, Hart DN.
    Eur J Immunol; 1996 Jun; 26(6):1204-10. PubMed ID: 8647193
    [Abstract] [Full Text] [Related]

  • 13. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B, Nash MA, Lenzi R, Platsoucas CD, Freedman RS.
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [Abstract] [Full Text] [Related]

  • 14. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.
    Munn DH, Sharma MD, Mellor AL.
    J Immunol; 2004 Apr 01; 172(7):4100-10. PubMed ID: 15034022
    [Abstract] [Full Text] [Related]

  • 15. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
    DiPaolo RJ, Unanue ER.
    J Immunol; 2002 Sep 15; 169(6):2832-6. PubMed ID: 12218093
    [Abstract] [Full Text] [Related]

  • 16. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions.
    Greene JL, Leytze GM, Emswiler J, Peach R, Bajorath J, Cosand W, Linsley PS.
    J Biol Chem; 1996 Oct 25; 271(43):26762-71. PubMed ID: 8900156
    [Abstract] [Full Text] [Related]

  • 17. Treatment of autoimmunity by inhibition of T cell costimulation.
    Daikh DI, Wofsy D.
    Adv Exp Med Biol; 2001 Oct 25; 490():113-7. PubMed ID: 11505969
    [No Abstract] [Full Text] [Related]

  • 18. CD4(+) T-cell activation is differentially modulated by bacteria-primed dendritic cells, but is generally down-regulated by n-3 polyunsaturated fatty acids.
    Brix S, Lund P, Kjaer TM, Straarup EM, Hellgren LI, Frøkiaer H.
    Immunology; 2010 Mar 25; 129(3):338-50. PubMed ID: 19909377
    [Abstract] [Full Text] [Related]

  • 19. Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells.
    Eck SC, Turka LA.
    Cancer Immunol Immunother; 1999 Sep 25; 48(6):336-41. PubMed ID: 10473809
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.